Skip to main content
. 2018 Sep 5;42(5):2515–2526. doi: 10.3892/ijmm.2018.3859

Figure 7.

Figure 7

Schematic illustration of metabolic pathways associated with cholestasis that were altered by MT treatment. Red and light blue boxes indicate metabolites with significantly higher and lower levels, respectively, in the cholestasis model when compared with the control group. Boxes bordered in red and blue represent metabolites with significantly higher and lower levels, respectively, in the MT treatment group when compared with the control rats. MT, melatonin.